Related Experiment Video
Updated: Apr 21, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient
Khalid Saeed1, Päivi Östling, Mari Björkman
1Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Abstract:
Hormonal therapies targeting androgen receptor (AR) are effective in prostate cancer (PCa), but often the cancers progress to fatal castrate-resistant disease. Improved understanding of the cellular events during androgen deprivation would help to identify survival and stress pathways whose inhibition could synergize with androgen deprivation. Toward this aim, we performed an RNAi screen on 2,068 genes, including kinases, phosphatases, epigenetic enzymes and other druggable gene targets. High-content cell spot microarray (CSMA) screen was performed in VCaP cells in the presence and absence of androgens with detection of Ki67 and cleaved ADP-ribose polymerase (cPARP) as assays for cell proliferation and apoptosis. Thirty-nine candidate genes were identified, whose silencing inhibited proliferation or induced apoptosis of VCaP cells exclusively under androgen-deprived conditions. One of the candidates, HSPB (heat shock 27 kDa)-associated protein 1 (HSPBAP1), was confirmed to be highly expressed in tumor samples and its mRNA expression levels increased with the Gleason grade. We found that strong HSPBAP1 immunohistochemical staining (IHC) was associated with shorter disease-specific survival of PCa patients compared with negative to moderate staining. Furthermore, we demonstrate that HSPBAP1 interacts with AR in the nucleus of PCa cells specifically during androgen-deprived conditions, occupies chromatin at PSA/klk3 and TMPRSS2/tmprss2 enhancers and regulates their expression. In conclusion, we suggest that HSPBAP1 aids in sustaining cell viability by maintaining AR signaling during androgen-deprived conditions.
Insights
Heat shock 27 kDa-associated protein 1 (HSPBAP1) helps prostate cancer cells survive androgen deprivation by maintaining androgen receptor (AR) signaling. Inhibiting HSPBAP1 may synergize with androgen deprivation therapy for advanced prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hormonal therapies targeting the androgen receptor (AR) are crucial for prostate cancer (PCa) treatment.
- PCa often progresses to fatal castrate-resistant disease despite hormonal therapy.
- Understanding cellular survival pathways during androgen deprivation is key to improving treatment efficacy.
Purpose of the Study:
- To identify novel survival and stress pathways involved in PCa progression during androgen deprivation.
- To find potential therapeutic targets that can synergize with androgen deprivation therapy.
Main Methods:
- Conducted an RNAi screen of 2,068 genes in VCaP cells under androgen-deprived conditions.
- Utilized high-content cell spot microarray (CSMA) with Ki67 and cleaved ADP-ribose polymerase (cPARP) assays.
- Confirmed candidate gene expression and protein localization via immunohistochemistry (IHC) and chromatin immunoprecipitation (ChIP).
Main Results:
- Identified 39 candidate genes that, when silenced, inhibited proliferation or induced apoptosis under androgen deprivation.
- HSPBAP1 (heat shock 27 kDa-associated protein 1) was a key candidate, highly expressed in tumors and correlated with higher Gleason grade.
- Strong HSPBAP1 IHC staining predicted shorter disease-specific survival in PCa patients.
- Demonstrated HSPBAP1 interacts with AR in the nucleus during androgen deprivation and regulates AR target gene enhancers (PSA/klk3, TMPRSS2/tmprss2).
Conclusions:
- HSPBAP1 plays a critical role in maintaining prostate cancer cell viability under androgen-deprived conditions.
- HSPBAP1 sustains AR signaling, suggesting it as a potential therapeutic target to overcome resistance to androgen deprivation therapy.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
Hedgehog Signaling Pathway
TGF - β Signaling Pathway

